Form 10-K405/A - Annual report [Sections 13 and 15(d), S-K Item 405]: [Amend]
SEC Accession No. 0000891618-01-501775
Filing Date
2001-08-24
Accepted
2001-08-24 00:00:00
Documents
9
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405/A PER END 12-31-2000 f75239a1e10-k405a.txt 10-K405/A 255340
3 EXHIBIT 10.7.2 f75239a1ex10-7_2.txt EX-10.7.2 17746
4 EXHIBIT 10.7.3 f75239a1ex10-7_3.txt EX-10.7.3 4748
5 EXHIBIT 10.13 f75239a1ex10-13.txt EX-10.13 82966
6 EXHIBIT 10.14 f75239a1ex10-14.txt EX-10.14 58361
7 EXHIBIT 10.15 f75239a1ex10-15.txt EX-10.15 10195
8 EXHIBIT 10.16 f75239a1ex10-16.txt EX-10.16 84078
9 EXHIBIT 10.18 f75239a1ex10-18.txt EX-10.18 130772
10 EXHIBIT 23.1 f75239a1ex23-1.txt EX-23.1 969
  Complete submission text file 0000891618-01-501775.txt   647636
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

EIN.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405/A | Act: 34 | File No.: 000-22570 | Film No.: 1723354
SIC: 2833 Medicinal Chemicals & Botanical Products